Have you ever wondered why some people seem to sail through a cold with barely a sniffle, while others are laid low by the same virus? It's a question that has intrigued scientists and medical professionals for years, and the answer may lie in an unexpected place: your nose.
Dr. Ellen Foxman, an associate professor at the Yale School of Medicine, has been exploring this very topic. Her journey began with a personal experience - witnessing her son's asthma attack, a frightening moment that sparked a scientific curiosity.
Foxman knew that rhinovirus infections, the most common cause of colds, can trigger asthma attacks. But what intrigued her was why the same virus could cause such varying reactions.
"Here's a virus that causes no symptoms in many people, yet for others, it can lead to life-threatening breathing difficulties. It's a fascinating enigma," Foxman explains.
Foxman and her team at Yale discovered that the key to this mystery might lie in the speed and effectiveness of our nasal cells' response to the virus. This response, known as the interferon response, varies from person to person. When this response is inhibited, it can lead to excessive mucus production and inflammation, as their study published in Cell Press Blue revealed.
"It's our body's reaction that determines the severity of the disease caused by the virus," Foxman emphasizes.
To reach this conclusion, Foxman and her colleagues grew nasal cells in a lab, allowing them to develop into a community of specialized cells similar to those found in our noses. They then infected these cells with rhinovirus and observed their reactions, noting the defenses activated in both infected and uninfected cells.
They found that a swift interferon response could restrict the rhinovirus infection to just a small fraction of nasal cells, potentially resulting in no symptoms or very mild ones. However, when the initial interferon response was blocked, a much larger proportion of cells became infected, leading to increased mucus production and inflammation.
But the question remains: What causes some people's interferon response to be weakened or blocked?
Foxman believes further research in real-life patients could provide answers. For now, she sees this study as a crucial first step towards understanding rhinovirus infections better.
Dr. Dan Barouch, director of the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center, agrees that the study is "very informative," but notes that the findings need to be confirmed in real-life rhinovirus infections to fully understand the variations in interferon responses.
He adds, "While this paper focuses on interferon, there could be other factors at play too."
Dr. Larry Anderson, a professor at Emory University School of Medicine, points out that the question of varying reactions to viral infections is not unique to rhinovirus. "With nearly all pathogens, we see different clinical outcomes in different people. Other factors, like the presence of certain bacteria, genetic differences, underlying illnesses, and prior immunity, can all play a role."
So, while we've taken a step forward in understanding the role of the nose in our response to colds, there's still much to uncover. As Foxman puts it, "This is just the beginning of our journey to unravel the mysteries of rhinovirus infections."
What do you think? Do you have any theories on why some people seem to be more resilient to colds than others? Share your thoughts in the comments!
